These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 5157399)

  • 1. [Pentaerythritol tetranitrate effects on electrocardiographic changes induced by glucose loading].
    Ferlito S; Bonaventura S
    Policlinico Med; 1971; 78(6):252-62. PubMed ID: 5157399
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the circulatory effect of the coronary dilator PETN].
    Tilsner V
    Med Klin; 1969 Jun; 64(24):1120-3. PubMed ID: 5809489
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative study on therapeutic efficacy of 2-benzofuryl-p-chlorophenyl carbinol (Clobenfurol) alone or in association with pentaerythritol tetranitrate].
    Martinelli M; Villecco A
    Minerva Cardioangiol; 1973 Jan; 21(1):60-6. PubMed ID: 4572004
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of a prolonged-action coronary vasodilator agent: pentaerythritol tetranitrate].
    Warembourg H; Théry C
    Lille Med; 1966; 11(6):742-5. PubMed ID: 5942195
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with a combined preparation (butydrine and pentaerythritol tetranitrate) in coronary insufficiency].
    Chiti E
    Clin Ter; 1970 May; 53(4):315-21. PubMed ID: 4394192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experimentation with a combination of a beta-blocking agent and a nitro derivative in the prevention of anginous crises and in the basic treatment of coronary insufficiency].
    Borroni G
    Clin Ter; 1970 May; 53(3):247-58. PubMed ID: 4393972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of "pentrium", drug improving coronary circulation].
    Wasyluk J; Ruźyllo E
    Pol Tyg Lek; 1966 Nov; 21(48):1853-4. PubMed ID: 5979531
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pentaerythritol "forte" in the treatment of coronary disease (author's transl)].
    Kawecka-Jaszcz K; Kocemba J; Moczurad K; Wójcikiewiczowa O
    Przegl Lek; 1978; 35(8):675-8. PubMed ID: 715249
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic possibilities in coronary disease].
    Zoli I; Baroncini S; Cornia GL; Donato S; Minore G; Pigini G; Pretolani E
    Minerva Med; 1973 Nov; 64(84):4445-57. PubMed ID: 4272415
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coronary therapy with Nitro-Sandolanid].
    Toker Y
    Munch Med Wochenschr; 1970 Apr; 112(17):809-12. PubMed ID: 5467991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of the systolic phase of the left ventricle in assessing the efficacy of therapy of patients with chronic coronary insufficiency].
    Shmeleva NK
    Ter Arkh; 1966 Sep; 38(9):77-81. PubMed ID: 4385082
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of coronary circulation disorders with Adenopurine].
    Mahr H
    Munch Med Wochenschr; 1966 Jan; 108(4):205-9. PubMed ID: 6013263
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical results of the use of a new drug association in heart diseases].
    Chierici F; Artuso P; Suriani L
    Clin Ter; 1970 Feb; 52(3):219-57. PubMed ID: 5419244
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of phosphocreatine on electrocardiographic changes induced by glucose load].
    Ferlito S; Bonaventura S
    Arch Maragliano Patol Clin; 1971; 27(5):195-204. PubMed ID: 5172806
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coronary therapy in geriatrics].
    Grübl M; Klein K; Siedek H
    Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
    Gruber G; Hambsch K
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):167-71. PubMed ID: 868090
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy and prevention of ischemic heart diseases].
    Gill E
    Z Allgemeinmed; 1973 Oct; 49(28):1354-6. PubMed ID: 4756675
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the objective evaluation of the effects of coronary vasoactive drugs].
    Lenti G; Cherchi A; Raffo M; Porrazzo G
    Minerva Med; 1966 Feb; 57(12):455-9. PubMed ID: 5910815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.